Please use this identifier to cite or link to this item: http://univ-bejaia.dz/dspace/123456789/21076
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTAOUZINET, Lamia-
dc.contributor.authorFATMI, Sofiane-
dc.contributor.authorLAHIANI-SKIBA, Malika-
dc.contributor.authorSKIBA, Mohamed-
dc.contributor.authorIGUER- OUADA, Mokrane-
dc.date.accessioned2023-02-07T14:03:12Z-
dc.date.available2023-02-07T14:03:12Z-
dc.date.issued2022-07-20-
dc.identifier.issn2800-1729-
dc.identifier.urihttp://univ-bejaia.dz/dspace/123456789/21076-
dc.description.abstractAbstract Size reduction is one of the most often utilized and important unit processes in pharmaceutical manufacture. It contributes to increased medicine safety and bioavailability, decreased toxicity, improved drug release, and improved drug formulation possibilities. Nanoencapsulation is a process that involves encapsulating a bioactive molecule in liquid, solid, or gaseous form within a matrix of inert material in order to preserve the coated component. The size of nanoencapsules can range from 1 to 1,000 nm. They have a multitude of different shapes, depending on the materials and methods used to prepare them. The main reason for nanoencapsulation species is to ensure that the encapsulated material reaches the area of action without being adversely affected by the external environment through which it passes. This research concentrated on current breakthroughs in nanoencapsulation drug systems, production, and characterization methodologies.en_US
dc.subjectNanoencapulationen_US
dc.subjectDrug deliveryen_US
dc.subjectSolubilityen_US
dc.titleNano-Encapsulation Systems Improve Drug Delivery and Solubilityen_US
dc.typeArticleen_US
Appears in Collections:Biopolymer Applications Journal (BAJ)

Files in This Item:
File Description SizeFormat 
5 TAOUZINET et al 2022.pdf398.49 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.